SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001403752-21-000016
Filing Date
2021-08-04
Accepted
2021-08-04 16:20:17
Documents
14
Period of Report
2021-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zyme-20210804.htm   iXBRL 8-K 48360
2 EX-99.1 exhibit991q2_2021xpressxre.htm EX-99.1 112411
6 zymeworkslogo.jpg GRAPHIC 15404
  Complete submission text file 0001403752-21-000016.txt   331763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zyme-20210804.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zyme-20210804_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zyme-20210804_pre.xml EX-101.PRE 12510
7 EXTRACTED XBRL INSTANCE DOCUMENT zyme-20210804_htm.xml XML 12223
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 211144299
SIC: 2834 Pharmaceutical Preparations